These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 14614021

  • 1. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M.
    Clin Cancer Res; 2003 Nov 01; 9(14):5358-69. PubMed ID: 14614021
    [Abstract] [Full Text] [Related]

  • 2. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F, Francescato P, Ragg E, Cattaneo MG, Pola S, Vicentini L.
    J Med Chem; 2003 Sep 11; 46(19):4165-72. PubMed ID: 12954068
    [Abstract] [Full Text] [Related]

  • 3. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.
    J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914
    [Abstract] [Full Text] [Related]

  • 4. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK, Johansson I, Akerud H, Einarsson B, Christofferson R, Sasaki T, Timpl R, Claesson-Welsh L.
    Cancer Res; 2004 Dec 15; 64(24):9012-7. PubMed ID: 15604266
    [Abstract] [Full Text] [Related]

  • 5. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
    Becker CM, Sampson DA, Short SM, Javaherian K, Folkman J, D'Amato RJ.
    Fertil Steril; 2006 Jan 15; 85(1):71-7. PubMed ID: 16412733
    [Abstract] [Full Text] [Related]

  • 6. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 7. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M, Dimmeler S.
    FASEB J; 2002 May 01; 16(7):706-8. PubMed ID: 11978735
    [Abstract] [Full Text] [Related]

  • 8. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 9. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z, Hou S.
    J Urol; 2003 Nov 28; 170(5):2000-3. PubMed ID: 14532841
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
    Taddei L, Chiarugi P, Brogelli L, Cirri P, Magnelli L, Raugei G, Ziche M, Granger HJ, Chiarugi V, Ramponi G.
    Biochem Biophys Res Commun; 1999 Sep 24; 263(2):340-5. PubMed ID: 10491294
    [Abstract] [Full Text] [Related]

  • 11. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
    Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP.
    Cancer Res; 1999 Jan 01; 59(1):189-97. PubMed ID: 9892206
    [Abstract] [Full Text] [Related]

  • 12. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 13. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N.
    Clin Cancer Res; 2002 Sep 20; 8(9):2933-8. PubMed ID: 12231538
    [Abstract] [Full Text] [Related]

  • 14. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
    Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW.
    Oncol Rep; 2004 Jan 20; 11(1):191-5. PubMed ID: 14654925
    [Abstract] [Full Text] [Related]

  • 15. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
    Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkilä P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T.
    Exp Cell Res; 2005 Jul 15; 307(2):292-304. PubMed ID: 15950618
    [Abstract] [Full Text] [Related]

  • 16. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.
    Curr Eye Res; 2006 Dec 15; 31(12):1033-45. PubMed ID: 17169842
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X, Bookstein R, Wills K, Avanzini J, Tsai V, LaFace D, Terracina G, Shi B, Nielsen LL.
    Cancer Gene Ther; 2001 Dec 15; 8(12):982-9. PubMed ID: 11781661
    [Abstract] [Full Text] [Related]

  • 18. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

  • 19. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
    Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S.
    Cancer Res; 2003 Aug 15; 63(16):5105-13. PubMed ID: 12941841
    [Abstract] [Full Text] [Related]

  • 20. In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane.
    Ma DH, Yao JY, Yeh LK, Liang ST, See LC, Chen HT, Lin KY, Liang CC, Lin KK, Chen JK.
    Invest Ophthalmol Vis Sci; 2004 Aug 15; 45(8):2586-95. PubMed ID: 15277481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.